Loading...
OTCM
CLPBY
Market cap13bUSD
Jun 18, Last price  
5.75USD
1D
-0.35%
1Q
-12.75%
Jan 2017
-14.56%
Name

Coloplast A/S

Chart & Performance

D1W1MN
OTCM:CLPBY chart
P/E
1.67
P/S
0.31
EPS
22.42
Div Yield, %
0.18%
Shrs. gr., 5y
1.08%
Rev. gr., 5y
8.54%
Revenues
27.03b
+10.33%
6,232,000,0006,709,000,0008,042,000,0008,463,000,0008,820,000,0009,537,000,00010,172,000,00011,023,000,00011,635,000,00012,428,000,00013,909,000,00014,681,000,00015,528,000,00016,449,000,00017,939,000,00018,544,000,00019,426,000,00022,579,000,00024,500,000,00027,030,000,000
Net income
5.05b
+5.62%
553,000,000466,000,000370,000,000715,000,000883,000,0001,243,000,0001,819,000,0002,194,000,0002,711,000,0002,390,000,000899,000,0003,143,000,0003,797,000,0003,845,000,0003,873,000,0004,197,000,0004,825,000,0004,706,000,0004,783,000,0005,052,000,000
CFO
2.77b
-34.55%
1,353,000,000966,000,0001,004,000,0001,324,000,0001,830,000,0001,769,000,0002,205,000,0002,649,000,0003,136,000,0003,149,000,0003,337,000,0003,028,000,0003,251,000,0004,361,000,0004,357,000,0004,759,000,0005,290,000,0005,099,000,0004,226,000,0002,766,000,000
Dividend
May 17, 20240.01047024 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Coloplast A/S designs, produces, and commercializes a range of medical devices. The firm concentrates on creating and marketing healthcare products and services aimed at individuals experiencing sensitive and private medical conditions. Its activities are segmented into four main areas: Ostomy Care, which supplies products for patients with a surgically rerouted intestinal tract; Continence Care, providing solutions for those with urinary system dysfunctions or damage; Urology Care, addressing issues affecting the kidneys, urinary tract, or the male reproductive system; and Wound & Skin Care, focused on the management of chronic wounds and the provision of both preventive and therapeutic skin care items. Coloplast distributes its merchandise to various entities, including hospitals, medical facilities, wholesalers, and pharmacies.
IPO date
Jan 01, 1983
Employees
14,700
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT